Throughout November, we gained some fascinating new insights into the potential of psychedelic medicine as researchers from some of the world’s leading institutions published their work. The month brought with it exciting new psychedelic research and some long-awaited results. Most notably, the official results of COMPASS Pathways‘ Phase IIb trial exploring the use of psilocybin in treating…
